We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Does H3K27M Mutation Impact Survival Outcome of High-Grade Spinal Cord Astrocytoma?
- Authors
Fan Zhang; Lei Cheng; Ze Ding; Shengxi Wang; Xingang Zhao; Zijun Zhao; Cong Liang; Kun Wu; Dongao Zhang; Yinqian Wang; Tao Fan
- Abstract
Objective: To evaluate the impact of H3K27M mutation in the prognosis of histological high-grade intramedullary astrocytoma. Methods: A total of 78 patients who were diagnosed with high-grade spinal cord astrocytoma were included. Clinical data consisting demographic, radiological, molecular features and treatment data were recorded. Univariate and multivariate Cox analysis were performed to investigate variables associated with survival outcome of histological high-grade spinal cord astrocytoma. Results: Median survival time was 21 months. Overall survival (OS) at 1 and 3 years was 65.7% and 40.7%, respectively. Sex, location, and tumor span did not present significant association with OS. Patients with H3K27M mutation showed significant shorter duration of symptom than patients with H3K27 wild-type. As respect to adjuvant treatment, adjuvant radiotherapy and chemotherapy were associated with favorable OS (both p = 0.01). Younger patients (age = 18 years) had shorter OS (p = 0.008) than adult patients (age > 18 years). Of note, H3K27M mutation did not show significant impact on the survival outcome, regardless of histology grade 3 or grade 4 (p = 0.3). Conclusion: Histological high-grade spinal cord astrocytoma has dismal prognosis. Our study demonstrated that H3K27M mutation did not show significant impact on survival outcome of histological high-grade spinal cord astrocytoma.
- Subjects
SURVIVAL rate; SPINAL cord; ASTROCYTOMAS; OVERALL survival; MULTIVARIATE analysis
- Publication
Neurospine, 2023, Vol 20, Issue 4, p1480
- ISSN
2586-6583
- Publication type
Article
- DOI
10.14245/ns.2346650.325